🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 128-week open-label study to assess the long-term safety and tole...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-30
Trial ID
NCT04084314
Treatments Being Tested
To evaluate the effect of erenumab compared to placebo on the change from b...
Status
Completed
Location
Research Site
Start Date
2015-07-20
Trial ID
NCT02483585
The main purpose of this study is to evaluate the effect of erenumab on med...
Status
Completed
Location
Rehabilitation and Neurological Services LLC
Start Date
2021-06-11
Trial ID
NCT04825678
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of erenumab in p...
Status
Completed
Location
LMU Klinikum München
Start Date
2021-12-02
Trial ID
NCT04970355
A phase 2a, multicenter, randomized, double-blind, placebo-controlled study...
Status
Completed
Location
Research Site
Start Date
2015-11-23
Trial ID
NCT02575833
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Sing...
Status
Completed
Location
Research Site
Start Date
2015-11-11
Trial ID
NCT02542605
Treatments Being Tested
A pharmacokinetic drug interaction study of erenumab and an oral contracept...
Status
Completed
Location
Research Site
Start Date
2016-02-12
Trial ID
NCT02792517
Treatments Being Tested
The primary objective of the study was to evaluate the effect of erenumab c...
Status
Completed
Location
Research Site
Start Date
2015-07-17
Trial ID
NCT02456740
A study to evaluate the effect of erenumab compared to placebo on the chang...
Status
Completed
Location
Research Site
Start Date
2013-08-06
Trial ID
NCT01952574
Treatments Being Tested
The primary objective of this study was to assess the effects of subcutaneo...
Status
Completed
Location
Research Site
Start Date
2016-02-22
Trial ID
NCT02741310
Treatments Being Tested